BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.9.0//EN
X-ORIGINAL-URL:https://courtsquaregroup.com/
X-WR-CALNAME:Court Square Group
X-WR-CALDESC:Driving the Business of Science
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-28699001e957dddc4221a528f36b32ad@courtsquaregroup.com
DTSTART:20261116T000000Z
DTEND:20261118T000000Z
DTSTAMP:20260901T232100Z
CREATED:20260901
LAST-MODIFIED:20260901
PRIORITY:5
SEQUENCE:4
TRANSP:OPAQUE
SUMMARY:Precision in Clinical Trials Oncology Summit
DESCRIPTION:\n	\n		\n			Boston is the central hub of the world’s most influential global cancer research environments. The Precision in Clinical Trials Oncology Summit Boston 2026 serves as the central platform where senior leaders from across the global oncology drug development ecosystem come together for two days of networking, collaboration, and strategic discussions.\nOncology Clinical Trials Conference Boston 2026 is a leading roadmap. The summit fosters advanced innovations, patient-centered research, and operational strategy in oncology study design. The summit is hosted within the Boston-Cambridge oncology corridor. Additionally, the event is held at a location known for pioneering breakthroughs in targeted cancer treatments, immunotherapy, and precision oncology.\nThis dynamic and advanced Boston oncology research ecosystem combines major innovators including Vertex Pharmaceuticals, AstraZeneca, Novartis Oncology, Bristol Myers Squibb, Merck & Co., Biogen, and Pfizer. The summit is home to the world’s renowned cancer research departments such as MIT Koch Institute for Integrative Cancer Research, Harvard Medical School, Boston Children’s Hospital, Massachusetts General Hospital Cancer Center, and Dana-Farber Cancer Institute.\nGreater Boston holds over 400 + active clinical trial sites and this makes it one of the world’s biggest oncology research institutions. The region continues to grow and lead advancements in CAR-T therapies, targeted cancer drug development, and precision medicine. Dana Farber is recognized among the top cancer hospitals worldwide. These features reinforce Boston’s position as the globally recognized leader in oncology innovation.\nThis ecosystem makes the Clinical Trials Oncology Summit the best forum where researchers can discuss operational strategies and the next generation of cancer therapies required to be delivered to patients faster.\nSummit Features\nThe Cancer Clinical Research Conference 2026 highlights the innovations that shape the future of oncology trials, such as:\n\n   Precision Oncology & Biomarker-Driven Therapies\n   CAR-T & Cellular Immunotherapy Trials\n   Targeted Cancer Therapeutics Development\n    Oncology Patient Recruitment & Retention\n    Real-World Evidence in Cancer Treatment\n\nWho Should Attend\n\nVice Presidents and Directors of Clinical Operations\nClinical Development Leaders\nRegulatory Affairs Executives\nOutsourcing & Vendor Management Professionals\n\nThe Precision in Clinical Trials Oncology Summit 2026 is a great opportunity for oncology researchers where they can exchange insights, explore different operational strategies, and build partnerships that shape the future of global drugs and cancer clinical development.\n\n		\n	\n\n
URL:https://courtsquaregroup.com/events/precision-in-clinical-trials-oncology/
LOCATION:Boston, MA
ATTACH;FMTTYPE=image/png:https://courtsquaregroup.com/wp-content/uploads/2026/09/PCT-Onc-Boston-2026.png
END:VEVENT
END:VCALENDAR